GlassScriptPhysician profile
Bether R Gerber
NPI 1275897365
$1,461.82
in general payments reported to CMS, 2019-2025
21 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $339 · 2023: $251 · 2024: $300 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $532.80 | 2024-2025 | Wegovy |
| Glaxosmithkline, LLC. | $186.72 | 2021-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $162.58 | 2022-2023 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.60 | 2021-2022 | |
| Abbvie INC. | $66.74 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $65.27 | 2021-2022 | |
| Gilead Sciences, INC. | $40.88 | 2021-2023 | Epclusa |
| Pfizer INC. | $34.30 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $33.32 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $32.49 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $32.32 | 2021 | |
| Lilly USA, LLC | $30.51 | 2021-2023 | Zepbound |
| Nestle Healthcare Nutrition INC. | $28.26 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.98 | 2021 | |
| Bard Peripheral Vascular, INC. | $24.28 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $22.34 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.45 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.59 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $15.32 | 2022 | |
| Esperion Therapeutics, INC. | $15.23 | 2022 | |
| Exact Sciences Corporation | $13.84 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bether Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.